Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Cell Stem Cell|September 2, 2022
Current status of cell-based interventions in JapanMisao Fujita, Taichi Hatta, Kazuki IdeRegenerative Medicine|March 24, 2017
Public attitudes in Japan towards human-animal chimeric embryo research using human induced pluripotent stem cellsTsutomu Sawai, Taichi Hatta, Misao FujitaStem Cell Reports|November 15, 2024
Amendments to ASRM: Can we move away from a "Therapeutic Haven"?Tsunakuni Ikka, Taichi Hatta, Misao FujitaStem Cell Reports|November 17, 2023
Does the Act on the Safety of Regenerative Medicine in Japan ensure "safety"?: Implications of low adverse event reportingTsunakuni Ikka, Taichi Hatta, Yoko Saito, et al.Future Science OA|November 29, 2021
Public attitudes in Japan toward the reproductive use of gametes derived from human-induced pluripotent stem cellsKyoko Akatsuka, Taichi Hatta, Tsutomu Sawai, et al.Stem Cell Reports|October 25, 2024
The urgent need for clear and concise regulations on exosome-based interventionsMisao Fujita, Taichi Hatta, Tsunakuni Ikka, et al.Frontiers in Genetics|July 10, 2023
Genome editing of human embryos for research purposes: Japanese lay and expert attitudesKyoko Akatsuka, Taichi Hatta, Tsutomu Sawai, et al.Regenerative Medicine|September 18, 2015
The current status of clinics providing private practice cell therapy in JapanMisao Fujita, Taichi Hatta, Reina Ozeki, et al.Drugs - Real World Outcomes|May 10, 2024
Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho DatabaseYohei Sobukawa, Taichi Hatta, Daito Funaki, et al.Future Science OA|November 29, 2021
Public attitudes in Japan toward the creation and use of gametes derived from human-induced pluripotent stem cellsTsutomu Sawai, Taichi Hatta, Kyoko Akatsuka, et al.Pageof 3